Back to ONC

BeOne Medicines Ltd. Additional Paid-in Capital 2015-2026 | ONC

Beta

What is BeOne Medicines Ltd.'s current additional paid-in capital?

BeOne Medicines Ltd. (ONC) annual additional paid-in capital for 2025 was $12.76B, a 5.55% increase from 2024. BeOne Medicines Ltd. additional paid-in capital for the quarter ending March 31, 2026 was $12.91B.

What was BeOne Medicines Ltd.'s additional paid-in capital in 2024?

BeOne Medicines Ltd. annual additional paid-in capital for 2024 was $12.09B, a 4.22% increase from 2023.

What was BeOne Medicines Ltd.'s additional paid-in capital in 2023?

BeOne Medicines Ltd. annual additional paid-in capital for 2023 was $11.60B, a 0.50% increase from 2022.

What is BeOne Medicines Ltd.'s 5-year additional paid-in capital CAGR?

BeOne Medicines Ltd. additional paid-in capital grew at a compound annual growth rate (CAGR) of 11.47% from FY2020 to FY2025, going from $7.41B to $12.76B over 5 years.

Additional Paid-in Capital History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+11.5%
FY2020
$7.41B
→
FY2025
$12.76B
1516171819202122232425
5 years selected
Additional Paid-in Capital History
PeriodValueChangeSource
FY2025$12.76B+5.6%10-K
FY2024$12.09B+4.2%10-K
FY2023$11.60B+0.5%10-K
FY2022$11.54B+3.1%10-K
FY2021$11.19B+50.9%10-K
FY2020$7.41B+153.4%10-K
FY2019$2.93B+6.6%10-K
FY2018$2.74B+174.3%10-K
FY2017$1.00B+69.3%10-K
FY2016$591.2M+3143.6%10-K
FY2015$18.2M-10-K
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →